Cis-9, trans- 11 and trans-10, cis-12 conjugated linoleic acid (CLA) do not affect the plasma lipoprotein profile in moderately overweight subjects with LDL phenotype B
- 1 September 2006
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 188 (1) , 167-174
- https://doi.org/10.1016/j.atherosclerosis.2005.10.019
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effects of Two Conjugated Linoleic Acid Isomers on Body Fat Mass in Overweight HumansObesity Research, 2004
- The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjectsBritish Journal of Nutrition, 2002
- DIETARY CONJUGATED LINOLEIC ACID IN HEALTH: Physiological Effects and Mechanisms of ActionAnnual Review of Nutrition, 2002
- Effect of supplementation with conjugated linoleic acid on human serum lipids and body fatThe Journal of Nutritional Biochemistry, 2001
- Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trialInternational Journal of Obesity, 2001
- The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humansLipids, 2001
- Conjugated Linoleic Acid Reduces Body Fat Mass in Overweight and Obese HumansJournal of Nutrition, 2000
- Mechanisms of Action of Conjugated Linoleic Acid: Evidence and SpeculationProceedings of the Society for Experimental Biology and Medicine, 2000
- Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis modelBritish Journal of Nutrition, 1999
- Conjugated linoleic acid and atherosclerosis in rabbitsAtherosclerosis, 1994